GARRETT GALT: Open Payments
NPI 1578207999 · CEDAR CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 11 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $390 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| BETA BIONICS, INC. | 2 | $36 |
| Corcept Therapeutics | 1 | $22 |
| Ascensia Diabetes Care Us Inc. | 1 | $22 |
| Tandem Diabetes Care, Inc. | 2 | $21 |
| Medtronic, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: LEQVIO, iLet Bionic Pancreas, Korlym, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, QULIPTA, TZIELD.
Industry payments across UT — which companies pay providers there.
